Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

HBCRegulatory press release05.11.2026 klo 19.47

Reference is made to the stock exchange announcements from Hofseth BioCare ASA ("HBC" or the "Company") published on 30 June 2026 regarding the resolution passed at the annual general meeting that remuneration payable to the board of directors of the Company (the "Board") for 2026 shall be paid through the issuance of ordinary shares to Board members. The general meeting further resolved to grant the Board authorisation to increase the share capital in the Company through the issuance of new shares with a total value of up to NOK 1,550,000, corresponding to 155,000,000 shares, each with a par value of NOK 0.01 (the "Board Authorisation").

Pursuant to the Board Authorisation, the Board resolved in a Board meeting held today, on 5 November 2026, to increase the share capital by NOK 2,375 through the issuance of 237,500 shares allocated to the members of the Board as remuneration for the first half of 2026. The allocation of shares is set out as follows and triggers a primary insider notification:

Linda Christin Hoff, a primary insider and member of the Board, has today, 5 November 2026, been allocated 50,000 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

Christoph Johannes Baldegger, a primary insider and member of the Board, has today, 5 November 2026, been allocated 37,500 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

Eva Maria Bech, a primary insider and member of the Board, has today, 5 November 2026, been allocated 37,500 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

Amy Bennett Novogratz, a primary insider and member of the Board, has today, 5 November 2026, been allocated 37,500 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

Crawford Linden Alexander Currie, a primary insider and member of the Board, has today, 5 November 2026, been allocated 37,500 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

In addition to the primary insiders as set out above, Roger Hofseth has today, 5 November 2026, been allocated 37,500 shares in HBC with a nominal value of NOK 0.01 per share, at a subscription price of NOK 0.01.

For further information, contact:
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This information is subject to the disclosure requirements in the Market Abuse Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Attachments

  • KRT-1500 Hoff
  • KRT-1500 Currie
  • KRT-1500 Baldegger
  • KRT-1500 Novogratz
  • KRT-1500 Bech